These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15478378)

  • 1. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulation for treatment of allergic disease.
    Nguyen TH; Casale TB
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity.
    Kawashima M; Miossec P
    Ann Rheum Dis; 2005 Mar; 64(3):415-8. PubMed ID: 15286007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IgE and other new immunomodulation-based therapies for allergic asthma.
    Jonkers RE; van der Zee JS
    Neth J Med; 2005 Apr; 63(4):121-8. PubMed ID: 15869039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bee venom modulates murine Th1/Th2 lineage development.
    Nam S; Ko E; Park SK; Ko S; Jun CY; Shin MK; Hong MC; Bae H
    Int Immunopharmacol; 2005 Aug; 5(9):1406-14. PubMed ID: 15953567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab and the immune system: an overview of preclinical and clinical data.
    Johansson SG; Haahtela T; O'Byrne PM
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):132-8. PubMed ID: 12197568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of transcription factor T-bet/GATA3 in lung cancer patients and its interference by the traditional Chinese herbal medicine].
    Wei H; Tian Z; Xu X; Feng J; Xiao W
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):34-7. PubMed ID: 11977633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-IgE and future treatments for respiratory allergies].
    Tunon-De-Lara JM; Raherison C; Berger P
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 1):114-20. PubMed ID: 12843997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7. Control of allergic airway inflammation through immunomodulation.
    Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis.
    Cheng Y; Zhang J; Hou W; Wang D; Li F; Zhang Y; Yuan F
    Int Immunopharmacol; 2009 Jul; 9(7-8):894-9. PubMed ID: 19336263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.